15.56

0.89% -0.14

Adma Biologics Inc (ADMA)

Overview News Price History Option Chain Financials Discussions Forecast

Adma Biologics Inc stock is traded at $15.56, with a volume of 2.82M. It is down -0.89% in the last 24 hours and up +4.08% over the past month. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Previous Close:

$15.70

Open:

$15.45

24h Volume:

2.82M

Relative Volume:

0.82

Market Cap:

$3.71B

Revenue:

$474.17M

Net Income/Loss:

$208.93M

P/E Ratio:

18.32

EPS:

0.8493

Net Cash Flow:

$65.61M

1W Performance:

+7.16%

1M Performance:

+4.08%

6M Performance:

-20.08%

1Y Performance:

-22.97%

1-Day Range:

$15.39

$15.90

1-Week Range:

$14.18

$16.67

52-Week Range:

$13.76

$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name

Adma Biologics Inc

Sector

Healthcare (1135)

Industry

Biotechnology (634)

Phone

(201) 478-5552

Address

C/O ADMA BIOLOGICS, INC., RAMSEY

Employee

685

Twitter

@AdmaBiologics

Next Earnings Date

2025-03-03

Latest SEC Filings

ADMA's Discussions on Twitter

Compare ADMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADMA Adma Biologics Inc	15.56	3.74B	474.17M	208.93M	65.61M	0.8493
VRTX Vertex Pharmaceuticals Inc	437.15	110.25B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	693.50	73.04B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	449.16	59.98B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	907.98	54.90B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	193.22	40.73B	447.02M	-1.18B	-906.14M	-6.1812

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-19-23	Resumed	Raymond James	Strong Buy
Oct-13-22	Initiated	Mizuho	Buy
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight
Jun-04-19	Initiated	Jefferies	Buy
Apr-15-19	Reiterated	H.C. Wainwright	Buy
Feb-07-19	Resumed	H.C. Wainwright	Buy
Dec-11-17	Reiterated	Maxim Group	Buy
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy
May-13-15	Reiterated	Maxim Group	Buy
Dec-08-14	Initiated	Oppenheimer	Outperform
Dec-01-14	Reiterated	Maxim Group	Buy

View All

Adma Biologics Inc Stock (ADMA) Latest News

02:27 AM

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - sharewise.com

02:27 AM

Nov 14, 2025

Applying Wyckoff theory to ADMA Biologics Inc. stockJuly 2025 PreEarnings & Verified Technical Trade Signals - newser.com

Nov 14, 2025

Nov 13, 2025

Risk adjusted return profile for ADMA Biologics Inc. analyzedJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com

Nov 13, 2025

Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com

Nov 13, 2025

Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors - sharewise.com

Nov 13, 2025

Nov 12, 2025

ADMA Biologics Inc Stock Analysis and ForecastVolatility Adjusted Trading & Actionable Entry & Exit Points Daily - earlytimes.in

Nov 12, 2025

Why ADMA Biologics' (NASDAQ:ADMA) Earnings Are Weaker Than They Seem - Yahoo Finance

Nov 12, 2025

Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade - sharewise.com

Nov 12, 2025

Nov 11, 2025

Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Volume Leaders & Reliable Entry Point Alerts - newser.com

Nov 11, 2025

Nov 10, 2025

(ADMA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Nov 10, 2025

Adma Biologics Shares Maintain Upward Momentum on Strong Financial Performance - AD HOC NEWS

Nov 10, 2025

Nov 08, 2025

Is ADMA Biologics Inc a good long term investmentEmerging Market Stocks & Capital Planning and Optimization - earlytimes.in

Nov 08, 2025

Nov 07, 2025

ADMA Biologics (ADMA) Is Down 8.1% After Raising Revenue Guidance Through 2029 Has The Bull Case Changed? - Yahoo Finance

Nov 07, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 07, 2025

Will ADMA Biologics Inc. stock continue dividend increasesBuy Signal & Expert Approved Trade Ideas - newser.com

Nov 07, 2025

ADMA Biologics Inc earnings matched, revenue topped estimates By Investing.com - Investing.com Australia

Nov 07, 2025

Nov 06, 2025

ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales - sharewise.com

Nov 06, 2025

ADMA Biologics Inc earnings matched, revenue topped estimates - Investing.com India

Nov 06, 2025

Adma Biologics: Q3 Earnings Snapshot - CT Insider

Nov 06, 2025

ADMA Biologics Ups Guidance After Outpacing Revenue Estimates - Finimize

Nov 06, 2025